Cytokinetics, Incorporated · NASDAQ:CYTK

Hessekiel Jeffrey sold 15,106 Cytokinetics, Incorporated shares (Form 4)

Traded Nov 17, 2026 · Filed Nov 18, 2026

On Nov 17, 2026, Hessekiel Jeffrey (Chief Legal & Admin Officer) sold 15,106 Cytokinetics, Incorporated shares at US$52.62 for US$795K, leaving 92,837 shares. Filed Nov 18, 2026 (Form 4).

Sold
15,106 shares
Price
US$52.62
Value
US$795K
Holding after
92,837 shares
Trading plan
No
Role
Chief Legal & Admin Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 17, 2026Common StockSale15,106US$52.6292,837Direct

Source

Download original · View original at SEC

Related